1.
Huang C, Wang Y, Li X, Ren L, et al. Clinical features of patientsinfected with 2019 novel coronavirus in Wuhan, China. Lancet2020; 395: 497-506.
2.
Stensland KD, Morgan TM, Moinzadeh A, et al. Considerations inthe triage of urologic surgeries during the COVID-19 pandemic.Eur Urol 2020; 77: 663-6.
3.
Ribal MJ, Cornford P, Briganti A, et al. European Associationof Urology Guidelines Office Rapid Reaction Group: AnOrganisation-wide Collaborative Effort to Adapt the EuropeanAssociation of Urology Guidelines Recommendations to theCoronavirus Disease 2019 Era. Eur Urol 2020;78: 21-8.
4.
Coronavirus Disease (COVID-19) Situation Reports [Internet].[cited 2021 Mar 28]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
5.
Wong J, Goh QY, Tan Z, et al. Preparing for a COVID-19 pandemic:a review of operating room outbreak response measures in a largetertiary hospital in Singapore. Can J Anaesth 2020; 67: 732-45.
6.
Keles E, Akis S, Kemal Ozturk U, Eser Ozyurek S, Api M.Gynecological surgeries during the COVID-19 pandemic inTurkey. Int J Gynaecol Obstet 2020; 151: 141-4.
7.
Tefik T, Guven S, Villa L, et al. Urolithiasis Practice PatternsFollowing the COVID-19 Pandemic: Overview from the EULISCollaborative Research Working Group. Eur Urol 2020; 78: e21-4.
8.
Proietti S, Gaboardi F, Giusti G. Endourological stone managementin the era of the COVID-19. Eur Urol 2020; 78: 131-3.
9.
Puliatti S, Eissa A, Eissa R, et al. COVID-19 and urology: acomprehensive review of the literature. BJU Int 2020; 125: E7-E14.
10.
Flammia S, Salciccia S, Tufano A, Busetto GM, Ricciuti GP,Sciarra A. How urinary stone emergencies changed in the time ofCOVID-19? Urolithiasis 2020; 48: 467-9.
11.
Al-Shamsi HO, Alhazzani W, Alhuraiji A, et al. A practicalapproach to the management of cancer patients during the novelcoronavirus disease 2019 (COVID-19) pandemic: an internationalcollaborative group. Oncologist 2020; 25: 936-45.
12.
Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2infection: a nationwide analysis in China. Lancet Oncol 2020; 21:335-7.
13.
Wang H, Zhang L. Risk of COVID-19 for patients with cancer.Lancet Oncol 2020; 21: e181.
14.
Zequi SC, Abreu D. Consideration in the management of renalcell carcinoma during the COVID-19 pandemic. Int Braz J Urol2020; 46: 69-78.
15.
Gravas S, Fournier G, Oya M, et al. Prioritising Urological Surgeryin the COVID-19 Era: A Global Reflection on Guidelines. EurUrol Focus 2020; 6: 1104-10.
16.
Professionals S-O. EAU Guidelines: Non-muscle-invasive BladderCancer [Internet]. Uroweb. [cited 2020 Dec 5]. Available from:https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/
17.
Esperto F, Pang KH, Albisinni S, Papalia R, Scarpa RM. Bladdercancer at the time of COVID-19 outbreak. Int Braz J Urol 2020;46: 62-8.
18.
Darlington CD, Mammen RJ, Mammen KJ. COVID-19 and itsimpact on genitourinary malignancies. Indian J Urol 2020; 36:163-170.
19.
Carneiro A, Wroclawski ML, Nahar B, et al. Impact of theCOVID-19 pandemic on the urologist’s clinical practice in Brazil:a management guideline proposal for low- and middle-incomecountries during the crisis period. Int Braz J Urol 2020; 46: 501-10.
20.
Nappi L, Ottaviano M, Rescigno P, et al. Italian Germ Cell CancerGroup (IGG) ERN-EURACAN Domain G3 GenitourinaryMedical Oncologists of Canada (GUMOC) Management ofgerm cell tumors during the outbreak of the novel coronavirusdisease-19 pandemic: a survey of international expertise centers.Oncologist 2020; 25: 1509-15.
21.
Bozkurt O, Sen V, Irer B, et al. Nation-wide analysis of the impactof the Covid-19 pandemic on daily urology practice in Turkey. IntJ Clin Pract 2021; 75: e13735.
22.
Icarra V, Novara G, Abrate A, et al. Urology practice during theCOVID-19 pandemic. Minerva Urol Nefrol 2020; 72: 369-75.
23.
Karagöz MA, Gül A, Borg C, et al. Influence of COVID-19pandemic on sexuality: a cross-sectional study among couples inTurkey. Int J Impot Res 2020; 33: 815-23.